High exposure to statins decrease the risk of new-onset dementia A nationwide population-based longitudinal cohort study

doi:10.1097/MD.0000000000016931

Chia Nan University of Pharmacy & Science Institutional Repository > 藥理學院 > 保健營養系(所) > 期刊論文 > Item 310902800/32598

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/32598

標題:	High exposure to statins decrease the risk of new-onset dementia A nationwide population-based longitudinal cohort study
作者:	Chang, Chih-Feng Liou, Yi-Sheng Lin, Tsung-Kun Ma, Stacey Hu, Yu-Ru Chen, Hung-Yi Jong, Gwo-Ping
貢獻者:	Armed Force Taichung Gen Hosp, Div Cardiol, Dept Internal Med Natl Def Med Ctr Taichung Vet Gen Hosp, Dept Family Med Natl Def Med Ctr, Sch Publ Hlth Med Affairs Bur, Armed Forces Med Supplies Off Univ Calif San Diego, La Jolla Chia Nan Univ Pharm & Sci, Div Nutr China Med Univ, Inst Pharm Chung Shan Med Univ Hosp, Div Internal Cardiol Chung Shan Med Univ, 110,Sect 1,Chien Kuo N Rd
關鍵字:	high exposure to statins hyperlipidemia new-onset dementia
日期:	2019-08
上傳時間:	2020-07-29 13:51:27 (UTC+8)
出版者:	LIPPINCOTT WILLIAMS & WILKINS
摘要:	Several studies have shown that statin users have a lower risk of new-onset dementia (NOD) compared nonusers. However, other studies have shown opposite results. In this study, we investigated the association between the use of statins and the development of NOD. This was a longitudinal cohort study using data from claim forms submitted to the Taiwanese Bureau of National Health Insurance. The study included patients with NOD and non-NOD subjects from January 2002 to December 2013. We estimated the hazard ratios (HRs) of NOD associated with statin use, whereas nonuser subjects were used as a reference group. A total of 19,522 NOD cases were identified in 100,610 hyperlipidemic patients during the study period. The risk of NOD, after adjusting for sex, age, comorbidities, and concurrent medication, was lower among statin users than nonusers (HR 0.95, 95% CI [ confidence interval] 0.94-0.96; P<. 001). The adjusted HRs for NOD were 1.53 (95% CI, 1.45-1.62), 0.63 (95% CI, 0.57-0.71), and 0.34 (95% CI, 0.30-0.38) when the cumulative defined daily doses ranged from 28 to 365, 366 to 730, and more than 730 relative to nonusers, respectively. Weconcluded that statin use is associated with a decreasedNODrisk. The protective effect of statins forNODseemedto be related to high exposure to statins. This study also highlights that high exposure to statins has a dose-response effect on lowering NOD risk.
關聯:	Medicine, v.98, n.34, e16931
顯示於類別:	[保健營養系(所) ] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
index.html		0Kb	HTML	1130	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....